COMP <GO>
VMD vs AGL // RETURN ON INVESTED CAPITAL (ROIC)
Viemed Healthcare Inc. (NASDAQ) VS. agilon health inc. (NYSE) • 15-METRIC TALLY: VMD 8
— AGL 1
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: VMD
LAST: $9.95 (-0.40%) • MKT CAP: $379.0M
roic
13.00%
LAST: $85.94 (-5.56%) • MKT CAP: $1.44B
roic
-35.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VMD VS. AGL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VMD | AGL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 57.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 13.00% | -35.00% | +48.00 | VMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.6x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 3.15% | -8.25% | +11.40 | VMD | /fcf-yield <GO> |
| Operating Margin | 8.50% | -7.80% | +16.30 | VMD | /operating-margins <GO> |
| Net Profit Margin | 5.70% | -6.60% | +12.30 | VMD | /net-margins <GO> |
| Revenue Growth (YoY) | 20.50% | -2.10% | +22.60 | VMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.59 | 2.06 | +4.53 | VMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 3/9 | +6.00 | VMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.1 | 44.0 | +9.10 | VMD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.7x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $379.0M | $1.44B | -$1.06B | AGL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VMD REV | AGL REV | VMD GROSS % | AGL GROSS % | VMD FCF | AGL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $270.3M | $5.93B | 57.5% | — | $11.9M | -$119.0M |
| FY 2024 | $224.3M | $6.06B | 59.4% | — | $1.3M | -$71.0M |
| FY 2023 | $183.0M | $4.32B | — | — | $45.2M | -$156.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VMD // BETA —
AGL // BETA —